- Home
- BEPC vs ADMA Comparison
BEPC vs ADMA Comparison
Compare BEPC & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEPC
- ADMA
- Stock Information
- Founded
- BEPC 2019
- ADMA 2004
- Country
- BEPC United States
- ADMA United States
- Employees
- BEPC N/A
- ADMA N/A
- Industry
- BEPC Electric Utilities: Central
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BEPC Utilities
- ADMA Health Care
- Exchange
- BEPC Nasdaq
- ADMA Nasdaq
- Market Cap
- BEPC 6.1B
- ADMA 5.1B
- IPO Year
- BEPC N/A
- ADMA N/A
- Fundamental
- Price
- BEPC $33.44
- ADMA $16.99
- Analyst Decision
- BEPC Buy
- ADMA Strong Buy
- Analyst Count
- BEPC 3
- ADMA 3
- Target Price
- BEPC $33.67
- ADMA $27.67
- AVG Volume (30 Days)
- BEPC 811.2K
- ADMA 3.5M
- Earning Date
- BEPC 08-01-2025
- ADMA 08-06-2025
- Dividend Yield
- BEPC 4.46%
- ADMA N/A
- EPS Growth
- BEPC N/A
- ADMA 469.09
- EPS
- BEPC N/A
- ADMA 0.85
- Revenue
- BEPC $3,882,000,000.00
- ADMA $474,174,000.00
- Revenue This Year
- BEPC $42.90
- ADMA $21.11
- Revenue Next Year
- BEPC $6.57
- ADMA $25.97
- P/E Ratio
- BEPC N/A
- ADMA $20.10
- Revenue Growth
- BEPC N/A
- ADMA 43.58
- 52 Week Low
- BEPC $23.73
- ADMA $13.50
- 52 Week High
- BEPC $37.00
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- BEPC 44.41
- ADMA 42.27
- Support Level
- BEPC $32.99
- ADMA $15.77
- Resistance Level
- BEPC $33.82
- ADMA $17.27
- Average True Range (ATR)
- BEPC 0.87
- ADMA 0.87
- MACD
- BEPC -0.35
- ADMA -0.11
- Stochastic Oscillator
- BEPC 16.11
- ADMA 42.00
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.